Clinical Trial Update: A Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for TQ-A3334 tablets evaluating tolerance, pharmacokinetics, and efficacy in phase 1 and phase 2 for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TQ-A3334 (TQ-A3334)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN